<DOC>
	<DOC>NCT02962674</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and performance of the ProstaCare System in relieving symptoms of urinary outflow obstruction secondary to benign prostatic hyperplasia.</brief_summary>
	<brief_title>ProstaCare Study for BPH</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Key Enrolled subjects must be at least 45 years of age, diagnosed with BPH requiring intervention. Subject must have symptoms and uroflowmetry results characteristic of BPH. Prostate must be of sufficient size to accommodate study device. Key Urethral morphology unable to accommodate study device. Active urinary tract infection. Interest in maintaining fertility. Past history of surgical intervention for BPH. History or current medical conditions contraindicating elective urological procedures.</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>BPH</keyword>
</DOC>